Sonnet BioTherapeutics, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Deficit) (Details Narrative)

Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)							1 Months Ended	3 Months Ended					9 Months Ended
	Dec. 10, 2024	Nov. 07, 2024	Jun. 21, 2024	Jun. 19, 2024	May 02, 2024	Oct. 26, 2023	Oct. 31, 2023	Jun. 30, 2025	Mar. 31, 2025	Dec. 31, 2024	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of common stock													$ 7,803,453	$ 3,899,157
Warrants to purchase shares											187,500			187,500
Issuance of share, value									$ 116,815	$ 7,622,619		$ 3,916,943
Financing costs incurred													465,200	$ 157,500
Proceeds from offering													$ 10,500,000
Warrant, shares								5,789,600					5,789,600
Shares released from abeyance, shares
Purchase and Registration Rights Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock avialable to be sold								$ 24,700,000					$ 24,700,000
Underwriting Agreement [Member] \| Chardan Capital Markets LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Shares for sale		155,000
Proceeds from offering		$ 4,200,000
Inducement Offer Letter Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price							$ 12.80
Warrant exercise price decrease							$ 9.60
Aggregate number of shares issued							353,562
Proceeds from issuance of warrants			$ 2,900,000
Warrant, shares								187,500					187,500
Shares released from abeyance, shares													$ 187,500
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of share, value									$ 10	$ 105		$ 16
Net share settlement of warrants, shares										1,209	92,493	1,795
Sale of common stock, net of issuance costs, shares									98,846	1,050,500		163,281
Shares released from abeyance, shares								$ 16		$ 3
Common Stock [Member] \| Purchase and Registration Rights Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Shares for sale													153,020
Issuance of share, value					$ 25,000,000.0
Volume weighted average price discount percentage					4.00%
Net proceeds													$ 200,000
Common Stock [Member] \| Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Financing costs incurred													$ 500,000
Prefunded Warrant [Member] \| Underwriting Agreement [Member] \| Chardan Capital Markets LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares		956,111
Offering price per share		$ 4.4999
Exercise price		$ 0.0001
Common Warrant [Member] \| Underwriting Agreement [Member] \| Chardan Capital Markets LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares		2,222,222
Offering price per share		$ 4.50
Exercise price		$ 4.50
Warrants term		5 years
Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Net share settlement of warrants, shares													2,419	96,090
Sale of common stock, net of issuance costs, shares													1,209	94,288
Number of warrant exercised														355,937
Warrant, shares											187,500			187,500
Proceeds from warrant exercises														$ 3,000,000.0
Pre-funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of warrant exercised													1,273,436
New Common Stock [Member] \| Inducement Offer Letter Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant, shares				703,125
Existing Warrant [Member] \| Inducement Offer Letter Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price							$ 12.80
Warrant exercise price decrease				$ 9.60
Warrant, shares				354.994
Existing Warrant Issued in June 2023 [Member] \| Inducement Offer Letter Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant, shares															28,409
Existing Warrant Issued in June 2023 [Member] \| Inducement Offer Letter Agreements [Member] \| Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price															$ 118.78
Expiration date															Jun. 21, 2029
Existing Warrant Issued in June 2023 [Member] \| Inducement Offer Letter Agreements [Member] \| Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price															$ 12.40
Expiration date															Dec. 30, 2026
New Common Stock Warrant [Member] \| Inducement Offer Letter Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price				$ 12.40
Warrants term				5 years
Placement Agent [Member] \| Inducement Offer Letter Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares				14,142
Exercise price				$ 14.88
Warrants term				5 years
Holder [Member] \| Common Stock Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Forfeited warrants, shares														4,302
October Offering [Member] \| Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of common stock						$ 3,900,000
Warrants to purchase shares						10,664
Exercise price						$ 16.00
October Offering [Member] \| Underwriters [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares for sale						163,281
October Offering [Member] \| Underwriters [Member] \| Prefunded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares						192,187
Offering price per share						$ 12.7992
Exercise price						$ 0.0008
October Offering [Member] \| Underwriters [Member] \| Common Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares						710,931
Offering price per share						$ 12.80
Exercise price						$ 12.80
Warrants term						5 years
October Offering [Member] \| Underwriters [Member] \| June 2024 Inducement Offer [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price decrease						$ 9.60
Registered Direct Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Offering price per share	$ 2.23
Proceeds from offering	$ 3,400,000
Registered Direct Offering [Member] \| Prefunded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Offering price per share	$ 2.2299
Registered Direct Offering [Member] \| Prefunded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Shares for sale	768,000
Warrants to purchase shares	317,325
Exercise price	$ 0.0001
Registered Direct Offering [Member] \| Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares	1,085,325
Exercise price	$ 2.10
Warrants term	5 years
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Offering price per share	$ 2.23
Private Placement [Member] \| Prefunded Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Shares for sale	127,500
Warrants to purchase shares	545,500
Exercise price	$ 0.0001
Private Placement [Member] \| Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares	673,000
Exercise price	$ 2.10
Warrants term	5 years